chevron_leftBack
As of 24 April 2025, BioStem Technologies, Inc. has a market cap of $190.09M USD, ranking #17421 globally and #2956 in the United States. It ranks #1736 in the Healthcare sector, and #487 in the Biotechnology industry.
Key Stats
Market Cap
$190.09MUSD
Enterprise Value
$171.65MUSD
Revenue (TTM)
$301.83MUSD
EBITDA (TTM)
$31.41MUSD
Net Income (TTM)
$31.88MUSD
EBITDA Margin
10%
Profit Margin
11%
PE Ratio
7.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Matuszewski
open_in_new
Employees
33
Founded
2006
Website
biostemtechnologies.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.8% | -8.1% | 8.1% | -17% | -5.6% | 23% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BSEM
BioStem Technologies Inc
ISIN: US0906842002
Shares Out.:
Shares Outstanding:
16.338M1
Shares Float:
11.854M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.70 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BioStem Technologies, Inc.
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
